5752 related articles for article (PubMed ID: 3260134)
1. Prognostic value of serial determinations of circulating immune complex levels in malignant melanoma.
Bukh A; Møller-Larsen A; Aguado MT; Møller-Larsen F; Møller NP
Cancer Immunol Immunother; 1988; 26(3):280-4. PubMed ID: 3260134
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of circulating immune complexes in patients with breast cancer.
Bukh A; Aguado MT; Krarup N; Poulsen HS; Nordentoft AM; Møller NP
Int J Cancer; 1988 Mar; 41(3):364-70. PubMed ID: 3257943
[TBL] [Abstract][Full Text] [Related]
3. Detection of IgA class circulating immune complexes bound to anti-C3d antibody in patients with IgA nephropathy.
Doi T; Kanatsu K; Sekita K; Yoshida H; Nagai H; Hamashima Y
J Immunol Methods; 1984 Apr; 69(1):95-104. PubMed ID: 6371143
[TBL] [Abstract][Full Text] [Related]
4. Primary lung cancer. A controlled study of preoperative and postoperative levels of circulating immune complexes.
Bukh A; Aguado MT; Kimose HH; Mouritzen C; Møoller NP
Cancer; 1988 May; 61(10):2033-41. PubMed ID: 3258788
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in malignant melanoma: serial studies in 130 patients.
Bharwani N; Campbell L; Ashley P; Queen WD; Phillips TM; Jerry LM
Oncology; 1986; 43(3):143-8. PubMed ID: 3703459
[TBL] [Abstract][Full Text] [Related]
6. Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study.
Swaak AJ; Groenwold J; Hannema A; Hack CE
Rheumatol Int; 1985; 5(5):215-20. PubMed ID: 3877968
[TBL] [Abstract][Full Text] [Related]
7. Search for circulating immune complexes and activation of the complement system in relation to estrogen treatment.
Bukh A; Jensen HK; Andersen HJ; Eriksen PB; Møller NP
Acta Obstet Gynecol Scand; 1987; 66(8):703-8. PubMed ID: 3329440
[TBL] [Abstract][Full Text] [Related]
8. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes and complement breakdown product C3d in glomerulonephritis and kidney transplantation.
Sølling J
Acta Pathol Microbiol Immunol Scand C; 1984 Aug; 92(4):213-20. PubMed ID: 6391086
[TBL] [Abstract][Full Text] [Related]
10. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
11. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
[TBL] [Abstract][Full Text] [Related]
14. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
15. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in human malignant melanoma.
D'Amelio R; Cooke B; Hobbs JR
Tumori; 1982 Dec; 68(6):469-72. PubMed ID: 7168010
[TBL] [Abstract][Full Text] [Related]
17. Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.
Anand D; Kumar U; Kanjilal M; Kaur S; Das N
Clin Exp Immunol; 2014 Jun; 176(3):327-35. PubMed ID: 24433281
[TBL] [Abstract][Full Text] [Related]
18. Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma.
Wong JH; Gupta RK; Morton DL
Arch Surg; 1986 Nov; 121(11):1342-5. PubMed ID: 3778209
[TBL] [Abstract][Full Text] [Related]
19. Serial circulating immune complex values and development of metastatic disease in breast cancer and malignant melanoma patients.
Ronai Z; Shaham J; Stein J; Sulitzeanu D
Cancer Immunol Immunother; 1986; 22(1):72-5. PubMed ID: 3518930
[TBL] [Abstract][Full Text] [Related]
20. Circulating antigens, immune complexes and C3d levels in human schistosomiasis: relationship with Schistosoma mansoni egg output.
Santoro F; Prata A; Castro CN; Capron A
Clin Exp Immunol; 1980 Nov; 42(2):219-25. PubMed ID: 7471514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
